Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1538157508
Hospital

San Joaquin Community Hospital

San Joaquin Community Hospital was paid $107.31M by Medicaid between Jan 2018 and Dec 2024, across 467 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.

33Billing provider infoSAN JOAQUIN COMMUNITY HOSPITAL
BAKERSFIELD, CA 93301
33aNPI1538157508assigned 10/12/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$107.31M
24GClaims2,507,860
24DCodes billed467
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#18 of 410
Median peer was paid$6.90M
This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018386,255$14.10M
2019396,961$13.90M
2020283,761$9.81M
2021298,477$11.11M
2022331,123$13.42M
2023399,525$20.10M
2024incomplete411,758$24.88M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 23% 83,404 59,689 $25.20M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 46,904 41,322 $17.29M
0762 7.0% 8,267 3,119 $7.48M
0450 Emergency room services 6.5% 47,763 41,636 $7.00M
J9271 Injection, pembrolizumab, 1 mg 5.8% 346 272 $6.23M
78815 Positron emission tomography (PET) for limited area imaging 3.9% 3,704 3,646 $4.15M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.1% 7,203 6,478 $3.37M
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 1.7% 303 128 $1.84M
74176 Computed tomography, abdomen and pelvis; without contrast material 1.6% 34,581 30,990 $1.75M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.4% 34,030 25,576 $1.55M
J9306 Injection, pertuzumab, 1 mg 1.1% 74 53 $1.22M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 14,639 13,537 $1.13M
455 more codes
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.0% 8,682 $1.10M
70450 Computed tomography, head or brain; without contrast material <1% 33,942 $1.02M
93458 <1% 453 $982K
0360 <1% 3,837 $869K
Q5116 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg <1% 82 $789K
80053 Comprehensive metabolic panel <1% 140,759 $663K
70551 Magnetic resonance imaging, brain; without contrast material <1% 7,143 $604K
71046 Radiologic examination, chest; 2 views <1% 57,669 $555K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,817 $509K
99214 Doctor's office visit, returning patient (more involved) <1% 12,205 $506K
71045 Radiologic examination, chest; single view <1% 87,687 $499K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 11,023 $486K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 157,093 $436K
72141 <1% 3,885 $404K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 456 $400K
77067 Screening mammography, bilateral, including computer-aided detection <1% 5,441 $397K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 2,297 $387K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 39,266 $382K
G0378 Hospital observation service, per hour <1% 650 $370K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 18,191 $348K
C1776 Joint device (implantable) <1% 53 $348K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 3,270 $339K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 18,549 $339K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,995 $331K
J3490 Unclassified drugs <1% 50,029 $331K
96549 <1% 330 $330K
Z7502 <1% 8,701 $326K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 11,161 $319K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 17,951 $317K
96375 Therapeutic injection; each additional sequential IV push <1% 40,125 $312K
97802 <1% 3,084 $308K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 2,250 $287K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 60,784 $285K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 9,951 $284K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 5,992 $279K
71250 <1% 5,369 $269K
76641 <1% 4,266 $269K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 13,526 $264K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 17,405 $236K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 4,753 $209K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,241 $206K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 6,648 $201K
J0185 Injection, aprepitant, 1 mg <1% 867 $199K
77066 Tomosynthesis, mammo <1% 1,896 $189K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 3,923 $188K
84443 Thyroid stimulating hormone (TSH) <1% 17,416 $176K
93970 <1% 4,105 $174K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 116 $173K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 39,983 $166K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,577 $158K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 306 $157K
J0897 Injection, denosumab, 1 mg <1% 78 $156K
93454 <1% 83 $156K
96367 <1% 4,308 $155K
Z9725 <1% 3,709 $147K
96417 <1% 3,044 $145K
99215 Doctor's office visit, returning patient (complex) <1% 2,160 $143K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,572 $141K
96361 Intravenous infusion, hydration; each additional hour <1% 19,518 $138K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,297 $134K
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session <1% 281 $132K
73221 <1% 1,025 $131K
81001 <1% 80,132 $130K
J9171 Injection, docetaxel, 1 mg <1% 33 $129K
J2785 Injection, regadenoson, 0.1 mg <1% 1,702 $128K
74246 <1% 1,591 $128K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,879 $127K
76830 Ultrasound, transvaginal <1% 5,076 $123K
97803 <1% 1,925 $115K
93971 <1% 4,763 $114K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 235 $112K
76770 <1% 2,915 $111K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 30,563 $108K
97804 <1% 3,238 $107K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,825 $102K
80061 Lipid panel <1% 13,602 $101K
J7030 Infusion, normal saline solution , 1000 cc <1% 37,959 $101K
76801 <1% 6,027 $101K
97162 <1% 1,591 $97K
80074 <1% 2,921 $96K
84484 <1% 52,661 $94K
76536 <1% 2,102 $93K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,423 $89K
84702 <1% 25,893 $88K
77049 <1% 357 $82K
72125 Computed tomography, cervical spine; without contrast material <1% 2,546 $81K
74178 <1% 338 $77K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 7,704 $74K
74018 <1% 6,932 $74K
78227 <1% 198 $73K
83880 <1% 25,013 $72K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,983 $72K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 561 $72K
80048 Basic metabolic panel (calcium, ionized) <1% 17,819 $71K
83036 Hemoglobin; glycosylated (A1C) <1% 11,827 $70K
27447 <1% 26 $70K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 35,533 $69K
70486 <1% 1,702 $69K
82607 <1% 6,028 $68K
83690 <1% 40,135 $67K
36905 <1% 18 $66K
0270 <1% 9,348 $66K
86803 <1% 27,829 $64K
82728 <1% 5,870 $63K
70496 <1% 1,020 $62K
J9070 Cyclophosphamide, 100 mg <1% 18 $61K
86780 <1% 29,997 $60K
76642 <1% 1,108 $59K
93017 <1% 1,782 $58K
99205 Prolong outpt/office vis <1% 634 $58K
99213 Doctor's office visit, returning patient (routine) <1% 2,137 $58K
83970 <1% 1,843 $58K
73562 <1% 5,040 $57K
96368 <1% 1,113 $54K
96523 <1% 2,461 $53K
77336 <1% 1,051 $53K
70544 <1% 474 $52K
75571 <1% 1,686 $51K
77427 <1% 412 $51K
J1750 Injection, iron dextran, 50 mg <1% 105 $51K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 7,710 $51K
72110 <1% 1,552 $50K
J7050 Infusion, normal saline solution, 250 cc <1% 11,718 $49K
73630 <1% 4,340 $49K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 15,761 $48K
0729 <1% 914 $48K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 29,707 $47K
85730 <1% 19,026 $46K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 3,111 $46K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,072 $45K
84466 <1% 4,820 $45K
82746 <1% 4,064 $44K
83735 <1% 20,353 $44K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 11,669 $43K
76870 <1% 1,646 $43K
72197 <1% 200 $43K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 6,397 $42K
96411 <1% 1,631 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,818 $40K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,816 $40K
73030 <1% 3,486 $40K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 7,860 $39K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 3,003 $39K
85610 <1% 23,975 $39K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 3,464 $38K
72081 <1% 1,356 $35K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,855 $35K
83540 <1% 6,576 $33K
J0640 Injection, leucovorin calcium, per 50 mg <1% 691 $33K
87040 <1% 17,076 $32K
17250 <1% 154 $32K
72100 <1% 2,543 $32K
73610 <1% 2,789 $32K
C9600 Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch <1% 12 $31K
84439 <1% 5,002 $31K
70498 <1% 927 $31K
83605 <1% 23,468 $31K
73130 <1% 2,541 $31K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,256 $30K
99223 Prolong inpt eval add15 m <1% 352 $29K
P9016 Red blood cells, leukocytes reduced, each unit <1% 440 $29K
J2704 Injection, propofol, 10 mg <1% 3,798 $28K
72131 <1% 475 $28K
97161 <1% 705 $26K
84100 <1% 10,325 $25K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 5,649 $25K
J9263 Injection, oxaliplatin, 0.5 mg <1% 254 $25K
99070 <1% 87,585 $24K
J2270 Injection, morphine sulfate, up to 10 mg <1% 26,651 $23K
59025 Fetal non-stress test <1% 807 $23K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,773 $22K
84480 <1% 1,924 $22K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,596 $21K
82378 <1% 2,062 $21K
73110 <1% 1,471 $21K
77065 Tomosynthesis, mammo <1% 348 $20K
85379 <1% 8,330 $20K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 588 $20K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 417 $18K
77300 <1% 105 $18K
73502 <1% 1,115 $17K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,564 $16K
86635 <1% 2,951 $16K
84153 <1% 1,555 $16K
86038 <1% 1,669 $16K
0510 <1% 545 $16K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 12 $15K
84425 <1% 784 $15K
99152 <1% 1,422 $15K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,556 $15K
85027 <1% 5,184 $15K
81025 <1% 7,440 $14K
73700 <1% 173 $14K
72052 <1% 363 $14K
71020 <1% 382 $13K
87186 <1% 4,278 $13K
96415 <1% 1,106 $13K
84550 <1% 3,749 $13K
72040 <1% 988 $12K
0160 <1% 287 $12K
74022 <1% 1,157 $12K
86140 <1% 4,819 $12K
96402 <1% 684 $12K
74247 <1% 105 $12K
86901 <1% 7,936 $12K
72050 <1% 381 $12K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 8,257 $11K
99495 <1% 454 $11K
87631 <1% 1,308 $11K
C2629 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser <1% 348 $11K
84403 <1% 655 $11K
J1953 Injection, levetiracetam, 10 mg <1% 633 $10K
99199 Unlisted special service, procedure or report <1% 164 $10K
73590 <1% 1,074 $10K
77080 <1% 264 $10K
99496 <1% 291 $10K
87522 Neg quan hep c or qual rna <1% 1,711 $10K
J1644 Injection, heparin sodium, per 1000 units <1% 3,776 $10K
71271 <1% 91 $10K
82948 <1% 6,528 $10K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 191 $9K
84436 <1% 1,666 $9K
80076 <1% 2,210 $9K
73080 <1% 685 $9K
86900 <1% 4,523 $9K
84145 <1% 2,499 $9K
J9267 Injection, paclitaxel, 1 mg <1% 108 $9K
90715 <1% 1,085 $9K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 413 $9K
82043 <1% 1,886 $9K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,994 $8K
87077 <1% 3,668 $8K
82550 <1% 4,614 $8K
82805 <1% 1,986 $8K
86850 <1% 4,182 $8K
0710 <1% 2,844 $8K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 919 $8K
83615 <1% 2,058 $7K
36415 Collection of venous blood by venipuncture <1% 6,079 $7K
71275 Computed tomographic angiography, chest, with contrast material <1% 365 $7K
82784 <1% 659 $7K
82962 <1% 6,194 $7K
85007 <1% 4,710 $7K
85652 <1% 4,327 $7K
J2060 Injection, lorazepam, 2 mg <1% 6,279 $7K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,116 $7K
84156 <1% 2,373 $7K
86481 <1% 111 $6K
72070 <1% 431 $6K
77338 <1% 16 $6K
82310 <1% 1,501 $6K
82105 <1% 176 $6K
97163 <1% 45 $6K
86300 <1% 533 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,258 $6K
V2632 Posterior chamber intraocular lens <1% 452 $6K
86431 <1% 1,293 $6K
70491 <1% 95 $6K
J9190 Injection, fluorouracil, 500 mg <1% 1,329 $6K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 1,944 $5K
70547 <1% 39 $5K
97116 <1% 619 $5K
85384 <1% 889 $5K
83521 <1% 225 $5K
82150 <1% 3,096 $5K
86334 <1% 409 $5K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 205 $5K
72072 <1% 200 $5K
84478 <1% 1,035 $5K
J3489 Injection, zoledronic acid, 1 mg <1% 188 $5K
84165 <1% 680 $5K
84481 <1% 393 $5K
86301 <1% 344 $5K
87081 <1% 2,267 $4K
0259 <1% 2,449 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,505 $4K
87340 <1% 777 $4K
77002 <1% 12 $4K
74174 <1% 168 $4K
S0028 Injection, famotidine, 20 mg <1% 825 $4K
93798 <1% 198 $4K
74183 <1% 12 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 235 $4K
83520 <1% 317 $4K
76882 <1% 279 $4K
J3360 Injection, diazepam, up to 5 mg <1% 1,289 $4K
86769 <1% 147 $3K
0250 <1% 1,271 $3K
76937 <1% 453 $3K
77012 <1% 111 $3K
86317 <1% 393 $3K
76818 <1% 60 $3K
82465 <1% 816 $3K
J1815 Injection, insulin, per 5 units <1% 3,550 $3K
0300 <1% 87 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,350 $3K
82140 <1% 1,358 $3K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 100 $3K
77001 <1% 343 $3K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 704 $3K
0324 <1% 120 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,244 $3K
J1120 Injection, acetazolamide sodium, up to 500 mg <1% 397 $3K
87070 <1% 582 $3K
J3370 Injection, vancomycin hcl, 500 mg <1% 1,686 $3K
99153 Mod sedat endo service >5yrs <1% 471 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 232 $3K
82010 <1% 2,105 $3K
73090 <1% 362 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,241 $3K
86704 <1% 334 $2K
77334 <1% 14 $2K
87205 <1% 1,811 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 270 $2K
P9011 Blood, split unit <1% 3,321 $2K
99232 Hospital visit by a doctor, follow-up day <1% 52 $2K
74170 <1% 12 $2K
82570 <1% 630 $2K
0761 <1% 101 $2K
97597 <1% 15 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 526 $2K
74019 <1% 386 $2K
85045 <1% 627 $2K
87210 <1% 1,695 $2K
86331 <1% 248 $2K
80143 <1% 1,005 $2K
73552 <1% 171 $2K
94760 <1% 217 $2K
32555 <1% 17 $2K
86923 <1% 421 $2K
93880 <1% 24 $2K
86592 <1% 1,927 $2K
S0164 Injection, pantoprazole sodium, 40 mg <1% 1,596 $2K
76819 Fetal biophysical profile; without non-stress testing <1% 32 $2K
87536 <1% 40 $2K
S0077 Injection, clindamycin phosphate, 300 mg <1% 398 $2K
74000 <1% 107 $2K
86171 <1% 236 $2K
73564 <1% 55 $2K
73140 <1% 152 $1K
71010 <1% 121 $1K
99204 Doctor's office visit, new patient (more involved) <1% 25 $1K
20610 <1% 12 $1K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 292 $1K
J2805 Injection, sincalide, 5 micrograms <1% 90 $1K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 274 $1K
84155 <1% 619 $1K
77072 <1% 83 $1K
82668 <1% 82 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 287 $1K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 12 $1K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 644 $1K
86335 <1% 57 $1K
80179 <1% 664 $1K
83010 <1% 101 $1K
J0780 Injection, prochlorperazine, up to 10 mg <1% 812 $1K
83013 <1% 16 $1K
93016 <1% 41 $986.36
86235 <1% 25 $924.67
86141 <1% 585 $920.42
84479 <1% 217 $903.32
73620 <1% 105 $890.86
76857 <1% 48 $873.77
82670 <1% 37 $829.11
73560 <1% 142 $806.44
Z9727 <1% 26 $780.00
87486 <1% 413 $775.82
87581 <1% 413 $775.82
87507 <1% 13 $762.53
86920 <1% 119 $748.53
86480 <1% 16 $739.68
Z7610 <1% 536 $724.41
J1790 Injection, droperidol, up to 5 mg <1% 305 $722.57
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 264 $702.43
82553 <1% 365 $654.71
J1940 Injection, furosemide, up to 20 mg <1% 1,256 $610.85
84154 <1% 38 $594.24
J0360 Injection, hydralazine hcl, up to 20 mg <1% 681 $569.80
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 226 $565.44
82731 <1% 31 $558.69
84270 <1% 26 $533.89
77417 <1% 34 $470.90
47562 <1% 12 $465.00
82248 <1% 183 $460.61
74181 <1% 13 $459.45
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) <1% 150 $455.76
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 36 $453.52
85018 <1% 106 $450.33
85014 <1% 103 $447.28
86593 <1% 737 $400.21
94664 <1% 301 $399.12
86694 <1% 38 $374.76
93308 <1% 13 $373.06
83516 <1% 41 $371.95
74328 <1% 17 $371.08
83001 <1% 23 $345.09
J9045 Injection, carboplatin, 50 mg <1% 171 $329.76
86701 <1% 62 $296.07
0258 <1% 175 $286.99
84166 <1% 30 $278.11
71101 <1% 26 $264.15
81003 <1% 64 $257.33
72170 <1% 49 $242.51
86880 <1% 46 $192.61
82533 <1% 34 $184.60
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 26 $178.63
J2470 Injection, pantoprazole sodium, 40 mg <1% 185 $169.27
87147 <1% 69 $164.22
73120 <1% 38 $161.52
12001 <1% 23 $159.96
J1170 Injection, hydromorphone, up to 4 mg <1% 511 $154.98
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 90 $151.32
83655 <1% 14 $148.82
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 119 $130.66
84132 <1% 313 $129.91
83014 <1% 16 $128.00
86039 <1% 16 $125.13
J8597 Antiemetic drug, oral, not otherwise specified <1% 146 $122.05
74230 <1% 13 $121.81
76000 <1% 25 $115.68
C1760 Closure device, vascular (implantable/insertable) <1% 62 $98.65
86225 <1% 12 $93.48
82272 <1% 62 $81.46
J1920 Injection, labetalol hydrochloride, 5 mg <1% 76 $77.14
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 12 $63.29
90674 <1% 32 $59.21
87088 <1% 63 $56.74
J2550 Injection, promethazine hcl, up to 50 mg <1% 227 $49.38
80164 <1% 13 $41.34
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 38 $41.00
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 56 $19.60
A4649 Surgical supply; miscellaneous <1% 551 $16.35
86308 <1% 14 $14.19
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 15 $9.90
85347 <1% 38 $6.89
J0456 Injection, azithromycin, 500 mg <1% 75 $1.61
0710R 0% 44 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 27 $0.00
J9000 Injection, doxorubicin hydrochloride, 10 mg 0% 34 $0.00
0258R 0% 108 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 21 $0.00
0370R 0% 88 $0.00
J9206 Injection, irinotecan, 20 mg 0% 32 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 30 $0.00
72128 0% 39 $0.00
0250R 0% 61 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 92 $0.00
0259R 0% 402 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 20 $0.00
J7999 Compounded drug, not otherwise classified 0% 52 $0.00
87493 0% 13 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 126 $0.00
87640 0% 41 $0.00
96376 0% 17 $0.00
J1836 Injection, metronidazole, 10 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWELLS, JASON (PRESIDENT)
Same official

Other billing entities under WELLS, JASON

Full network →
ProviderLocationPaid
Adventist Health Medical Center TehachapiTehachapi, CA$17.97M
Adventist Health Medical Center TehachapiMojave, CA$4.47M
Adventist Health Medical Center TehachapiTehachapi, CA$3.98M
Adventist Health Medical Center TehachapiCalifornia City, CA$3.93M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.